Breaking News, Collaborations & Alliances

BioMed X, Janssen Enter Oral Drug Delivery Alliance

Aims to discover novel transport mechanisms which could be utilized for oral delivery of therapeutic modalities.

Author Image

By: Charlie Sternberg

Associate Editor

German independent research institute BioMed X has announced a new research project with Janssen Research & Development LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, which aims to discover novel transport mechanisms in the human intestinal tract which could be utilized for oral delivery of diverse therapeutic modalities.   Biologics such as monoclonal antibodies have transformed the treatment of immune-related diseases, but need to be delivered by injection, wh...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters